Thank you Commissioner @OliverVarhelyi for the exciting news of the upcoming Safe Hearts Plan. For the first time, Europe shares a clear vision: to reduce premature cardiovascular deaths by 2030 and to ensure equitable, high-quality prevention, innovation and long-term support

Have you explored this month’s great ESC FOCUS resources on valvular heart disease (VHD)? Be sure to sign up for the 17 December webinar ‘2025 #ESCGuidelines on valvular heart disease: what's new in mitral regurgitation?’ It’s free and will help you understand and implement the

Last in the trilogy! Bench to Bedside: From Results to Patient Care Topic: GLP-1 RAs and HFpEF – Which patients should receive them? Monday, 15 December | 18:00–19:00 CET. Register now – free for everyone👉 https://t.co/jxaxrINZl5 Missed Webinar 2? Watch on demand👉

#EAPCI26 Summit @escardio 📆Munich 19-20 February 🇩🇪 ⭐️Become an #EAPCI member 🌸 Enjoy 🆓 Registration to #EAPCi26 Summit 🌸 If you had your abstract accepted & applied you might be one of the 2️⃣0️⃣0️⃣ travel grants recipients #EAPCIfamily #EAPCIcommunity #riseandlift

This month, the Science Committee is introducing Lien Desteghe who enjoys her job in committee since its a way to foster research collaborations and identify key research priorities #ACNAP @DionCandelaria_ @J_Hendriks1

1️⃣ How to use GLP-1 RA in patients with #HeartFailure? New #EJHF expert consensus document, a thread🧵: 📍Eligible pts: #HFpEF + #obesity (BMI ≥30 kg/m2) 📍Avoid/caution: #HFrEF, #worseningHF, #ESRD, prior pancreatitis, severe GI intolerance 📍Start low, titrate every 4 weeks

🧵 Thread | EACVI 2025 Congress – Vienna 🇦🇹 1/ What an incredible EACVI 2025 Congress in Vienna. My heartfelt thanks to the global cardiovascular imaging community for making this the largest cardiovascular imaging congress in Europe. @escardio @NAjmoneMarsan @rmanka_

Absolutely over the moon for my friend and colleague @neiljcraig who has won not only one but BOTH #EACVI2025 Young Investigator Award categories in what must be a first 🤩 😳 Incredibly proud and delighted to see your hard work recognised 💪🏼the perfect ending to a great meeting

Day 3 at #EACVI2025! Another amazing day of science, collaboration and inspiration! 🤗🤩😍

A quick moment at #EACVI2025 with @EchoSoliman , #EACVI Secretary, & Pr #FrankTimmermans, reflecting on the congress & their shared interest in #Doppler imaging🫀🤗 #EACVImotions @escardio @EACVIPresident #EchoFirst #WhyCMR #YesCCT #ThinkPET

@misako_desu , a sonographer from #Japan & JSE Young Investigator Awardee 🏆, is happy to be here in Vienna for #EACVI2025 She recently presented her work on the impact of mitral annular disjunction on systolic dynamics of the mitral annulus & leaflets in Barlow’s disease

Innovative assessments of myocardial function using myocardial strain by @TomazP3 #EACVI2025 @escardio how to assess

Shaping today's conferences with tomorrow's leaders in mind! 🌟 #EACVI2025 🎧Hear from Dr. Luna Latorre 🔥Let's amplify mentorship and sponsorship for future women cardiologists. 👠 They are our heartbeat of the future! 💖 #WomenInCardiology #MentorshipMatters

Excited to have met @DrHebaMD @ClevelandClinic #EACVI2025 Bringing the top US cardio-rheumatologist to #vienna 🌍✨ She's thrilled by the positive collaboration and innovation in tackling cardiovascular and rheumatic diseases. Cardio-Rheum is bridging gaps for heart health! 🫀🤝

#whyCMR use in #ICI #myocarditis by @LarsMichelMD : 📍Pathophysiology differs from viral myocarditis 📍CMR remains central, but sensitivity is limited, especially when LVEF ≥50% 📍CMR findings must be integrated with echo, biomarkers & clinical context 📍Early endomyocardial

Great congress memories for #EACVI2025 @escardio see you in Milán. Amazing science and networking as usual @EACVIPresident @Sarah_Moharem @ydaryani @slumberbell @VDelgadoGarcia @denisamuraru @DrGEMandoli @Giulia_Vinco @AnnaKateBarton @hrt01a @ybououdina @BirkhoelzerS

Precision matters in #cardiooncology imaging by @dr_manisty 🧲 📍CMR is central for accurate #cardiotoxicity surveillance 📍Tissue characterisation helps define mechanism, not just detect dysfunction 📍Under-diagnosis harms CV outcomes; over-diagnosis may compromise cancer care

Why CMR 🧲 matters in contemporary #CardioOncology by @AnaBaracCardio🫀 📍 Early & accurate detection of CV risk, CVD, & CTRCD before, during, & after therapy 📍Confirms #myocarditis & #pericarditis 📍Uncovers #HFpEF etiologies (#amyloid, #ischemic, #infiltrativeCMP ) 📍Enables

Packed room at very early in the morning at our session on critical care echocardiography on last day of #EACVI2025! Impressive attendance and interest in the topic #echofirst #POCUS

#EACVI2025 is the largest multimodality imaging congress, & you can really feel the energy here Hear from Prof. #AnaTeresaTimoteo, Chair of the #EACVI Education Committee from Portugal, & @JeanneOngSY , who came all the way from Singapore🫀 #EACVImotions @escardio

Inge Edler and Liv Hatle lecture on #echofirst #EACVI2025 By one & only Gerald Maurer Past Present Future @EACVIPresident @escardio @Sarah_Moharem @slumberbell @rafavidalperez @VDelgadoGarcia @denisamuraru @DrGEMandoli